The news is directly about ArcBest. UBS analyst's decision to maintain a Neutral rating indicates that they do not expect significant changes in the stock's performance. However, the increase in the price target from $110 to $119 suggests a positive outlook for the company's stock in the future. This could potentially attract investors, but the impact is likely to be neutral in the short term as the rating remains unchanged.